{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,24]],"date-time":"2025-10-24T08:08:10Z","timestamp":1761293290228,"version":"build-2065373602"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2025,6,20]],"date-time":"2025-06-20T00:00:00Z","timestamp":1750377600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,6,20]],"date-time":"2025-06-20T00:00:00Z","timestamp":1750377600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Acta Pharmacol Sin"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1038\/s41401-025-01606-7","type":"journal-article","created":{"date-parts":[[2025,6,20]],"date-time":"2025-06-20T07:41:08Z","timestamp":1750405268000},"page":"2998-3008","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Molecular recognition of two approved drugs Macimorelin and Anamorelin by the growth hormone secretagogue receptor"],"prefix":"10.1038","volume":"46","author":[{"given":"Ruo-lan","family":"Wang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Heng","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shi-meng","family":"Guo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wen","family":"Hu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"You-wen","family":"Zhuang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yi","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xin","family":"Xie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H. Eric","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yue","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,6,20]]},"reference":[{"key":"1606_CR1","doi-asserted-by":"publisher","first-page":"4679","DOI":"10.1073\/pnas.0305930101","volume":"101","author":"Y Sun","year":"2004","unstructured":"Sun Y, Wang P, Zheng H, Smith RG. Ghrelin stimulation of growth hormone release and appetite is mediated through the growth hormone secretagogue receptor. Proc Natl Acad Sci USA. 2004;101:4679\u201384.","journal-title":"Proc Natl Acad Sci USA"},{"key":"1606_CR2","doi-asserted-by":"publisher","first-page":"124","DOI":"10.2337\/diabetes.51.1.124","volume":"51","author":"Y Date","year":"2002","unstructured":"Date Y, Nakazato M, Hashiguchi S, Dezaki K, Mondal MS, Hosoda H, et al. Ghrelin is present in pancreatic \u03b1-cells of humans and rats and stimulates insulin secretion. Diabetes. 2002;51:124\u20139.","journal-title":"Diabetes"},{"key":"1606_CR3","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1254\/jphs.CRJ06002X","volume":"100","author":"H Hosoda","year":"2006","unstructured":"Hosoda H, Kojima M, Kangawa K. Biological, physiological, and pharmacological aspects of ghrelin. J Pharm Sci. 2006;100:398\u2013410.","journal-title":"J Pharm Sci"},{"key":"1606_CR4","doi-asserted-by":"publisher","first-page":"974","DOI":"10.1126\/science.273.5277.974","volume":"273","author":"AD Howard","year":"1996","unstructured":"Howard AD, Feighner SD, Cully DF, Arena JP, Liberator PA, Rosenblum CI, et al. A receptor in pituitary and hypothalamus that functions in growth hormone release. Science. 1996;273:974\u20137.","journal-title":"Science"},{"key":"1606_CR5","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1038\/45230","volume":"402","author":"M Kojima","year":"1999","unstructured":"Kojima M, Hosoda H, Date Y, Nakazato M, Matsuo H, Kangawa K. Ghrelin is a growth-hormone-releasing acylated peptide from stomach. Nature. 1999;402:656\u201360.","journal-title":"Nature"},{"key":"1606_CR6","doi-asserted-by":"publisher","DOI":"10.1042\/BSR20181061","volume":"38","author":"Y Lv","year":"2018","unstructured":"Lv Y, Liang T, Wang G, Li Z. Ghrelin, a gastrointestinal hormone, regulates energy balance and lipid metabolism. Biosci Rep. 2018;38:BSR20181061.","journal-title":"Biosci Rep"},{"key":"1606_CR7","doi-asserted-by":"publisher","first-page":"2225","DOI":"10.1016\/j.peptides.2011.09.019","volume":"32","author":"MD Gahete","year":"2011","unstructured":"Gahete MD, C\u00f3rdoba-Chac\u00f3n J, Kineman RD, Luque RM, Casta\u00f1o JP. Role of ghrelin system in neuroprotection and cognitive functions: implications in Alzheimer\u2019s disease. Peptides. 2011;32:2225\u20138.","journal-title":"Peptides"},{"key":"1606_CR8","doi-asserted-by":"publisher","first-page":"2222","DOI":"10.1016\/j.peptides.2010.08.019","volume":"31","author":"A Beiras-Fernandez","year":"2010","unstructured":"Beiras-Fernandez A, Kreth S, Weis F, Ledderose C, P\u00f6ttinger T, Dieguez C, et al. Altered myocardial expression of ghrelin and its receptor (GHSR-1a) in patients with severe heart failure. Peptides. 2010;31:2222\u20138.","journal-title":"Peptides"},{"key":"1606_CR9","doi-asserted-by":"publisher","first-page":"2988","DOI":"10.1210\/jcem.87.6.8739","volume":"87","author":"S Gnanapavan","year":"2002","unstructured":"Gnanapavan S, Kola B, Bustin SA, Morris DG, McGee P, Fairclough P, et al. The tissue distribution of the mRNA of ghrelin and subtypes of its receptor, GHS-R, in humans. J Clin Endocrinol Metab. 2002;87:2988\u201391.","journal-title":"J Clin Endocrinol Metab"},{"key":"1606_CR10","doi-asserted-by":"publisher","first-page":"259","DOI":"10.2337\/diabetes.54.1.259","volume":"54","author":"A Baessler","year":"2005","unstructured":"Baessler A, Hasinoff MJ, Fischer M, Reinhard W, Sonnenberg GE, Olivier M, et al. Genetic linkage and association of the growth hormone secretagogue receptor (ghrelin receptor) gene in human obesity. Diabetes. 2005;54:259\u201367.","journal-title":"Diabetes"},{"key":"1606_CR11","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2024.103322","volume":"76","author":"X Xiao","year":"2024","unstructured":"Xiao X, Tang T, Bi M, Liu J, Liu M, Jiao Q, et al. GHSR deficiency exacerbates Parkinson\u2019s disease pathology by impairing autophagy. Redox Biol. 2024;76:103322.","journal-title":"Redox Biol"},{"key":"1606_CR12","doi-asserted-by":"publisher","first-page":"920","DOI":"10.1161\/01.HYP.0000215180.32274.c8","volume":"47","author":"A Baessler","year":"2006","unstructured":"Baessler A, Kwitek AE, Fischer M, Koehler M, Reinhard W, Erdmann J, et al. Association of the Ghrelin receptor gene region with left ventricular hypertrophy in the general population: results of the MONICA\/KORA Augsburg Echocardiographic Substudy. Hypertension. 2006;47:920\u20137.","journal-title":"Hypertension"},{"key":"1606_CR13","doi-asserted-by":"crossref","unstructured":"Smith RG, Cheng K, Pong S-S, Leonard R, Cohen CJ, Arena JP, et al. Mechanism of Action of GHRP-6 and Nonpeptidyl Growth Hormone Secretagogues. In: Bercu BB,Walker RF, Editors. Growth Hormone Secretagogues. (Springer New York, New York, NY, 1996), p 147\u201363.","DOI":"10.1007\/978-1-4612-2396-2_11"},{"key":"1606_CR14","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1016\/j.ctrv.2015.09.002","volume":"41","author":"A Esposito","year":"2015","unstructured":"Esposito A, Criscitiello C, Gelao L, Pravettoni G, Locatelli M, Minchella I, et al. Mechanisms of anorexia-cachexia syndrome and rational for treatment with selective ghrelin receptor agonist. Cancer Treat Rev. 2015;41:793\u20137.","journal-title":"Cancer Treat Rev"},{"key":"1606_CR15","doi-asserted-by":"publisher","DOI":"10.1210\/endocr\/bqaa020","volume":"161","author":"MA Hedegaard","year":"2020","unstructured":"Hedegaard MA, Holst B. The complex signaling pathways of the ghrelin receptor. Endocrinology. 2020;161:bqaa020.","journal-title":"Endocrinology"},{"key":"1606_CR16","unstructured":"MACRILEN. Prescribing Information. Aeterna Zentaris GmbH; 2017. https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2017\/205598s000lbl.pdf."},{"key":"1606_CR17","unstructured":"GHRYVELIN. Summary of Product Characteristics. Aeterna Zentaris GmbH; 2019. https:\/\/www.ema.europa.eu\/en\/documents\/product-information\/ghryvelin-epar-product-information_en.pdf."},{"key":"1606_CR18","unstructured":"Anamorelin Hydrochloride. Review Report. Ono Pharmaceutical Co., Ltd.; 2019. https:\/\/www.pmda.go.jp\/files\/000242929.pdf."},{"key":"1606_CR19","doi-asserted-by":"publisher","first-page":"1191","DOI":"10.1021\/jm020985q","volume":"46","author":"V Guerlavais","year":"2003","unstructured":"Guerlavais V, Boeglin D, Mousseaux D, Oiry C, Heitz A, Deghenghi R, et al. New active series of growth hormone secretagogues. J Med Chem. 2003;46:1191\u2013203.","journal-title":"J Med Chem"},{"key":"1606_CR20","doi-asserted-by":"publisher","first-page":"RC26","DOI":"10.1007\/BF03345096","volume":"25","author":"F Broglio","year":"2002","unstructured":"Broglio F, Boutignon F, Benso A, Gottero C, Prodam F, Arvat E, et al. EP1572: a novel peptido-mimetic GH secretagogue with potent and selective GH-releasing activity in man. J Endocrinol Invest. 2002;25:RC26\u2013RC8.","journal-title":"J Endocrinol Invest"},{"key":"1606_CR21","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1210\/edrv-16-1-63","volume":"16","author":"HD Boer","year":"1995","unstructured":"Boer HD, Blok G-J, Veen EAVD. Clinical aspects of growth hormone deficiency in adults. Endocr Rev. 1995;16:63\u201386.","journal-title":"Endocr Rev"},{"key":"1606_CR22","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1530\/eje.1.01873","volume":"152","author":"M Maghnie","year":"2005","unstructured":"Maghnie M, Aimaretti G, Bellone S, Bona G, Bellone J, Baldelli R, et al. Diagnosis of GH deficiency in the transition period: accuracy of insulin tolerance test and insulin-like growth factor-I measurement. Eur J Endocrinol. 2005;152:589\u201396.","journal-title":"Eur J Endocrinol"},{"key":"1606_CR23","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1530\/eje.0.1330305","volume":"133","author":"HC Hoeck","year":"1995","unstructured":"Hoeck HC, Vestergaard P, Jakobsen PE, Laurberg P. Test of growth hormone secretion in adults: poor reproducibility of the insulin tolerance test. Eur J Endocrinol. 1995;133:305\u201312.","journal-title":"Eur J Endocrinol"},{"key":"1606_CR24","doi-asserted-by":"publisher","first-page":"2422","DOI":"10.1210\/jc.2013-1157","volume":"98","author":"JM Garcia","year":"2013","unstructured":"Garcia JM, Swerdloff R, Wang C, Kyle M, Kipnes M, Biller B, et al. Macimorelin (AEZS-130)-stimulated growth hormone (GH) test: validation of a novel oral stimulation test for the diagnosis of adult GH deficiency. J Clin Endocrinol Metab. 2013;98:2422\u20139.","journal-title":"J Clin Endocrinol Metab"},{"key":"1606_CR25","doi-asserted-by":"publisher","first-page":"3083","DOI":"10.1210\/jc.2018-00665","volume":"103","author":"JM Garcia","year":"2018","unstructured":"Garcia JM, Biller BM, Korbonits M, Popovic V, Luger A, Strasburger CJ, et al. Macimorelin as a diagnostic test for adult GH deficiency. J Clin Endocrinol Metab. 2018;103:3083\u201393.","journal-title":"J Clin Endocrinol Metab"},{"key":"1606_CR26","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1530\/EC-20-0491","volume":"10","author":"JM Garcia","year":"2021","unstructured":"Garcia JM, Biller BM, Korbonits M, Popovic V, Luger A, Strasburger CJ, et al. Sensitivity and specificity of the macimorelin test for diagnosis of AGHD. Endocr Connect. 2021;10:76\u201383.","journal-title":"Endocr Connect"},{"key":"1606_CR27","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1159\/000519232","volume":"94","author":"V Cs\u00e1kv\u00e1ry","year":"2021","unstructured":"Cs\u00e1kv\u00e1ry V, Ammer N, Bagci EB, Bolshova OV, Damholt BB, Katanic D, et al. Safety, tolerability, pharmacokinetics, and pharmacodynamics of macimorelin in children with suspected growth hormone deficiency: an open-label, group comparison, dose-escalation trial. Horm Res Paediatr. 2021;94:239\u201350.","journal-title":"Horm Res Paediatr"},{"key":"1606_CR28","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1016\/j.ghir.2008.12.003","volume":"19","author":"JM Garcia","year":"2009","unstructured":"Garcia JM, Polvino WJ. Pharmacodynamic hormonal effects of anamorelin, a novel oral ghrelin mimetic and growth hormone secretagogue in healthy volunteers. Growth Horm IGF Res. 2009;19:267\u201373.","journal-title":"Growth Horm IGF Res"},{"key":"1606_CR29","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/S1470-2045(14)71154-4","volume":"16","author":"JM Garcia","year":"2015","unstructured":"Garcia JM, Boccia RV, Graham CD, Yan Y, Duus EM, Allen S, et al. Anamorelin for patients with cancer cachexia: an integrated analysis of two phase 2, randomised, placebo-controlled, double-blind trials. Lancet Oncol. 2015;16:108\u201316.","journal-title":"Lancet Oncol"},{"key":"1606_CR30","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1016\/S1470-2045(15)00558-6","volume":"17","author":"JS Temel","year":"2016","unstructured":"Temel JS, Abernethy AP, Currow DC, Friend J, Duus EM, Yan Y, et al. Anamorelin in patients with non-small-cell lung cancer and cachexia (ROMANA 1 and ROMANA 2): results from two randomised, double-blind, phase 3 trials. Lancet Oncol. 2016;17:519\u201331.","journal-title":"Lancet Oncol"},{"key":"1606_CR31","doi-asserted-by":"publisher","first-page":"1949","DOI":"10.1093\/annonc\/mdx192","volume":"28","author":"D Currow","year":"2017","unstructured":"Currow D, Temel J, Abernethy A, Milanowski J, Friend J, Fearon K. ROMANA 3: a phase 3 safety extension study of anamorelin in advanced non-small-cell lung cancer (NSCLC) patients with cachexia. Ann Oncol. 2017;28:1949\u201356.","journal-title":"Ann Oncol"},{"key":"1606_CR32","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1038\/nrc3829","volume":"14","author":"JM Argil\u00e9s","year":"2014","unstructured":"Argil\u00e9s JM, Busquets S, Stemmler B, L\u00f3pez-Soriano FJ. Cancer cachexia: understanding the molecular basis. Nat Rev Cancer. 2014;14:754\u201362.","journal-title":"Nat Rev Cancer"},{"key":"1606_CR33","first-page":"1","volume":"2024","author":"AS Rivas","year":"2023","unstructured":"Rivas AS, \u00c1lvarez YE, Cordellat AB, Tarruella MM, Mata KM, de la C\u00e1mara MM, et al. SEOM clinical guidelines for cancer anorexia-cachexia syndrome. Clin Transl Oncol 2023;2024:1\u201311.","journal-title":"Clin Transl Oncol"},{"key":"1606_CR34","doi-asserted-by":"publisher","DOI":"10.1002\/cam4.7170","volume":"13","author":"K Takayama","year":"2024","unstructured":"Takayama K, Kojima A, Honda C, Nakayama M, Kanemata S, Endo T, et al. Real\u2010world safety and effectiveness of anamorelin for cancer cachexia: Interim analysis of post\u2010marketing surveillance in Japan. Cancer Med. 2024;13:e7170.","journal-title":"Cancer Med"},{"key":"1606_CR35","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-25364-2","volume":"12","author":"Y Wang","year":"2021","unstructured":"Wang Y, Guo S, Zhuang Y, Yun Y, Xu P, He X, et al. Molecular recognition of an acyl-peptide hormone and activation of ghrelin receptor. Nat Commun. 2021;12:5064.","journal-title":"Nat Commun"},{"key":"1606_CR36","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-26735-5","volume":"12","author":"H Liu","year":"2021","unstructured":"Liu H, Sun D, Myasnikov A, Damian M, Baneres J-L, Sun J, et al. Structural basis of human ghrelin receptor signaling by ghrelin and the synthetic agonist ibutamoren. Nat Commun. 2021;12:6410.","journal-title":"Nat Commun"},{"key":"1606_CR37","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-17554-1","volume":"11","author":"Y Shiimura","year":"2020","unstructured":"Shiimura Y, Horita S, Hamamoto A, Asada H, Hirata K, Tanaka M, et al. Structure of an antagonist-bound ghrelin receptor reveals possible ghrelin recognition mode. Nat Commun. 2020;11:4160.","journal-title":"Nat Commun"},{"key":"1606_CR38","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-27975-9","volume":"13","author":"J Qin","year":"2022","unstructured":"Qin J, Cai Y, Xu Z, Ming Q, Ji S-Y, Wu C, et al. Molecular mechanism of agonism and inverse agonism in ghrelin receptor. Nat Commun. 2022;13:300.","journal-title":"Nat Commun"},{"key":"1606_CR39","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1038\/s41586-018-0219-7","volume":"558","author":"A Koehl","year":"2018","unstructured":"Koehl A, Hu H, Maeda S, Zhang Y, Qu Q, Paggi JM, et al. Structure of the \u00b5-opioid receptor\u2013Gi protein complex. Nature. 2018;558:547\u201352.","journal-title":"Nature"},{"key":"1606_CR40","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1038\/nature10361","volume":"477","author":"SG Rasmussen","year":"2011","unstructured":"Rasmussen SG, DeVree BT, Zou Y, Kruse AC, Chung KY, Kobilka TS, et al. Crystal structure of the \u03b22 adrenergic receptor\u2013Gs protein complex. Nature. 2011;477:549\u201355.","journal-title":"Nature"},{"key":"1606_CR41","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1021\/op0502506","volume":"10","author":"BJ Paul","year":"2006","unstructured":"Paul BJ, Littler BJ, Jos F, Vogt PF, Pines SH. A practical synthesis of the pseudotripeptide RC-1291. Org Process Res Dev 2006;10:339\u201345.","journal-title":"Org Process Res Dev"},{"key":"1606_CR42","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1038\/nmeth.4193","volume":"14","author":"SQ Zheng","year":"2017","unstructured":"Zheng SQ, Palovcak E, Armache J-P, Verba KA, Cheng Y, Agard DA. MotionCor2: anisotropic correction of beam-induced motion for improved cryo-electron microscopy. Nat Methods. 2017;14:331\u20132.","journal-title":"Nat Methods"},{"key":"1606_CR43","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1038\/nmeth.4169","volume":"14","author":"A Punjani","year":"2017","unstructured":"Punjani A, Rubinstein JL, Fleet DJ, Brubaker MA. cryoSPARC: algorithms for rapid unsupervised cryo-EM structure determination. Nat Methods. 2017;14:290\u20136.","journal-title":"Nat Methods"},{"key":"1606_CR44","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-18952-1","volume":"11","author":"T Bepler","year":"2020","unstructured":"Bepler T, Kelley K, Noble AJ, Berger B. Topaz-Denoise: general deep denoising models for cryoEM and cryoET. Nat Commun. 2020;11:5208.","journal-title":"Nat Commun"},{"key":"1606_CR45","doi-asserted-by":"publisher","first-page":"2126","DOI":"10.1107\/S0907444904019158","volume":"60","author":"P Emsley","year":"2004","unstructured":"Emsley P, Cowtan K. Coot: model-building tools for molecular graphics. Acta Crystallogr D Biol Crystallogr. 2004;60:2126\u201332.","journal-title":"Acta Crystallogr D Biol Crystallogr"},{"key":"1606_CR46","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1107\/S0907444909052925","volume":"66","author":"PD Adams","year":"2010","unstructured":"Adams PD, Afonine PV, Bunk\u00f3czi G, Chen VB, Davis IW, Echols N, et al. PHENIX: a comprehensive Python-based system for macromolecular structure solution. Acta Crystallogr D Biol Crystallogr. 2010;66:213\u201321.","journal-title":"Acta Crystallogr D Biol Crystallogr"},{"key":"1606_CR47","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1002\/pro.3943","volume":"30","author":"EF Pettersen","year":"2021","unstructured":"Pettersen EF, Goddard TD, Huang CC, Meng EC, Couch GS, Croll TI, et al. UCSF ChimeraX: structure visualization for researchers, educators, and developers. Protein Sci. 2021;30:70\u201382.","journal-title":"Protein Sci"},{"key":"1606_CR48","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1016\/j.ab.2010.09.030","volume":"408","author":"J-P Leyris","year":"2011","unstructured":"Leyris J-P, Roux T, Trinquet E, Verdi\u00e9 P, Fehrentz J-A, Oueslati N, et al. Homogeneous time-resolved fluorescence-based assay to screen for ligands targeting the growth hormone secretagogue receptor type 1a. Anal Biochem. 2011;408:253\u201362.","journal-title":"Anal Biochem"}],"container-title":["Acta Pharmacologica Sinica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41401-025-01606-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41401-025-01606-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41401-025-01606-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,24]],"date-time":"2025-10-24T08:03:56Z","timestamp":1761293036000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41401-025-01606-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,20]]},"references-count":48,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2025,11]]}},"alternative-id":["1606"],"URL":"https:\/\/doi.org\/10.1038\/s41401-025-01606-7","relation":{},"ISSN":["1671-4083","1745-7254"],"issn-type":[{"type":"print","value":"1671-4083"},{"type":"electronic","value":"1745-7254"}],"subject":[],"published":{"date-parts":[[2025,6,20]]},"assertion":[{"value":"12 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 June 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"HEX is a founder of Cascade Pharmaceutics. All the other authors declare no other competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}